Owned by Fresenius
This facility is owned by Fresenius, one of two companies that control over two-thirds of all dialysis facilities in the United States. Research has found that when large chains acquire independent clinics, transplant referral rates tend to decline while hospitalization and infection rates increase. Compare this facility's outcomes with independent clinics in your area.
Below-Average Patient Survival
This facility has a standardized mortality ratio of 18.60, which is above the national average of 1.0. This means patient survival at this clinic is lower than expected.
BIO-MEDICAL APPLICATIONS OF FREMONT
39505 PASEO PADRE PARKWAY
Fremont, CA 94538
CMS Quality of Patient Care Rating
Source: CMS Dialysis Facility Compare (data.cms.gov). Updated quarterly.
Overall Rating
★★★★★Composite of patient outcomes, safety, and experience
Patient Survival
★★★★★Based on standardized mortality ratio
Hospitalizations
★★★★★Rate of hospital admissions relative to expected
Infections
★★★★★Bloodstream infection rate relative to national average
Patient Experience
Not ratedICH-CAHPS patient survey results
Patient Outcome Data
Ratios below 1.0 indicate better-than-expected outcomes. Above 1.0 means worse than the national average.
Standardized Mortality Ratio (SMR)
18.60
Below 1.0 = better survival
Standardized Hospitalization Ratio (SHR)
166.30
Below 1.0 = fewer hospitalizations
Standardized Infection Ratio (SIR)
0.12
Below 1.0 = fewer infections
Standardized Readmission Ratio (SRR)
35.40
Below 1.0 = fewer readmissions
Transplant Referrals & Vascular Access
Higher transplant referral rates and fistula usage generally indicate better patient-centered care. High catheter usage increases infection risk.
Transplant Referral Rate
2%
% of patients referred for transplant evaluation
Transplant Waitlist Rate
37%
% of patients on the kidney transplant waitlist
Fistula Rate
61%
Fistula is the preferred, lower-infection access method
Catheter Rate
21%
High catheter use = higher infection risk. Warning >15%
Frequently Asked Questions
What is BIO-MEDICAL APPLICATIONS OF FREMONT's CMS star rating?▲
BIO-MEDICAL APPLICATIONS OF FREMONT has a 4-star CMS Quality of Patient Care rating out of 5, based on patient survival, hospitalization rates, infection rates, and other clinical measures.
Who owns BIO-MEDICAL APPLICATIONS OF FREMONT?▲
BIO-MEDICAL APPLICATIONS OF FREMONT is owned by Fresenius. Fresenius is one of two companies that control over two-thirds of all dialysis facilities in the United States.
What is BIO-MEDICAL APPLICATIONS OF FREMONT's transplant referral rate?▲
2% of eligible patients at BIO-MEDICAL APPLICATIONS OF FREMONT have been referred for kidney transplant evaluation, according to CMS data.
What is BIO-MEDICAL APPLICATIONS OF FREMONT's infection rate?▲
BIO-MEDICAL APPLICATIONS OF FREMONT has a standardized infection ratio (SIR) of 0.12. A ratio below 1.0 means fewer infections than the national average; above 1.0 means more infections than expected.
Grow your business in Fremont
Get verified, receive leads, and stand out from competitors.
Claim This ListingAbout This Data
All data is sourced directly from the CMS Dialysis Facility Compare dataset (data.cms.gov) and updated quarterly. DialysisCenterUSA receives no compensation from this facility or its parent company.
CMS Certification Number (CCN): 052722
Quick Facts
Ask about availability
Contact this facility about open chairs and scheduling. This does not affect their CMS rating — we never let facility payments influence rankings.
Call (510) 659-1240